FinanceCity
DiversifiedNSE · BSE

Hester Biosciences Ltd

HESTERBIO · ISIN INE782E01017

Share price

₹2,047 -0.95%

Market capitalisation

₹1741 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹1741 Cr

Current price

₹2,047

-0.95% today

52W high

₹2,350

52W low

₹1,239

Stock P/E

30.29

P/B ratio

4.83

02 · Per share & returns

EPS (TTM)

₹67.58

Book value

₹423

ROE

16.56%

ROA

6.36%

Dividend yield

0.34%

Beta

0.5

03 · Financials (TTM)

By the numbers

Revenue

₹333 Cr

+38.20% YoY

EBITDA

₹86.66 Cr

Net profit

₹55.64 Cr

+968.70% YoY

Profit margin

16.73%

Operating margin

28.39%

Total debt

₹195 Cr

Total cash

₹6.54 Cr

Debt / equity

0.53x

Current ratio

1.37x

Payout ratio

10.36%

04 · Analyst view

Target price

Upside

Consensus

NONE

Analysts

05 · Shareholding pattern

Who owns HESTERBIO?

Shareholding pattern not yet captured for this company. Pulled from NSE corporate filings on the next ownership refresh.

06 · Registration & listing

On the record

Symbol
HESTERBIO
Exchange
NSE · BSE
CIN
ISIN
INE782E01017
BSE code
524669
Sector
Diversified
Industry
Face value
₹10
Listing date
12 Mar 2015
Employees
Headquarters
Mehsana, India

07 · About

What is Hester Biosciences Ltd?

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through the Poultry Healthcare and Animal Healthcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers vaccines for peste des petits ruminants, goat pox, brucella abortus, lumpy skin disease, contagious bovine pleuropneumonia, and contagious caprine pleuropneumonia for cattle, buffalo, sheep, and goats; and diagnostic services. In addition, the company provides animal healthcare products, such as biosecurity solutions, therapeutic treatment, herbal supplements, homeopathic remedies, and feed supplements. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticides, grooming aids, and anti-infective formulations; and healthcare products, such as immune boosters, gut health enhancers, vitamins, minerals and specialty feed supplements, and various formulations for critical needs comprising disease prevention, growth, and nutritional balance. Additionally, the company provides sero-profiling kits, diagnostic labs for poultry flocks, and mastitis control programs for cattle; and manufactures and trades in goods. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Mehsana, India.

08 · Common questions

Frequently asked

What is the CIN of Hester Biosciences Limited?+

The Corporate Identity Number for Hester Biosciences Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Hester Biosciences Limited?+

Promoter and group-holding details for Hester Biosciences Limited are disclosed quarterly via stock-exchange filings. Detailed pattern is refreshed weekly here from BSE and NSE corporate filings.

What is the market capitalisation of Hester Biosciences Limited?+

Hester Biosciences Limited (HESTERBIO) has a market capitalisation of approximately ₹1741 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other diversified listings

Full sector →